Apriem Advisors’s VivoSim Labs VIVS Stock Holding History

Apriem Advisors’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-1	Closed	-$2K	–	527
2013 Q4	$2K	Hold	1	–	–	﹤0.01%	471
2013 Q3	$1K	Buy	+1	New	+$1.4K	﹤0.01%	485

Other funds holding VIVS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Apriem Advisors's VIVS Position: Q1 2014 in Review

Apriem Advisors sold out of VivoSim Labs (VIVS) in Q1 2014, closing a stake of 1 share — an estimated $2K sold.

Apriem Advisors first reported a position in VIVS in Q3 2013 and held it in 2 quarters. The position peaked at $2K in Q4 2013. 94 funds tracked by Wall St. Rank hold VIVS as of Q1 2014.

Apriem Advisors reported no remaining VivoSim Labs position as of Q1 2014 after selling out during the quarter.
Apriem Advisors sold 1 VivoSim Labs share in Q1 2014, an estimated $2K.
Apriem Advisors first reported a position in VivoSim Labs in Q3 2013 and held it in 2 quarters.
Apriem Advisors's VivoSim Labs position peaked at $2K in Q4 2013.
94 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2014.

Based on Apriem Advisors's 13F filing for Q1 2014, filed 13 May 2014.